Trijardy XR 10 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 10 mg/1

Trijardy XR 10 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control and may reduce cardiovascular risks. Ideal for those requiring combination therapy.

Strength

10 mg/1

Pack Size

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0380-68)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 10 mg/1 is primarily used for managing type 2 diabetes in adults. It combines three active ingredients to help control blood sugar levels. This medication is often prescribed when diet and exercise alone are not sufficient. It may also support cardiovascular health in certain patients.

Side Effects

Common effects of Trijardy XR 10 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when starting treatment. Some users may experience urinary tract infections or low blood sugar. These effects vary and typically subside as the body adjusts to the medication.

Precautions & Warnings

Handle Trijardy XR 10 mg/1 with care, especially if you have kidney issues or a history of pancreatitis. Always follow your healthcare provider's instructions. Store the medication safely and keep it out of reach of children. Regular monitoring of blood sugar levels is recommended.

Avoid Interactions

Trijardy XR 10 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol and some over-the-counter medications can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Trijardy XR 10 mg/1 is used to manage type 2 diabetes in adults by controlling blood sugar levels.

Trijardy XR 10 mg/1 is taken orally, typically once daily with a meal, as directed by your healthcare provider.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and low blood sugar.

Alcohol may interact with Trijardy XR 10 mg/1 and affect its efficacy. Consult your healthcare provider for personalized advice.

Trijardy XR 10 mg/1 is not suitable for everyone. It is typically prescribed for adults who require combination therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.